.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
US Army
UBS
AstraZeneca
Merck
Mallinckrodt
McKinsey
Express Scripts
Colorcon

Generated: November 24, 2017

DrugPatentWatch Database Preview

Novel Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?

NOVEL LABS INC has fifty-three approved drugs.

There are two tentative approvals on NOVEL LABS INC drugs.

Summary for Novel Labs Inc

US Patents:0
Tradenames:42
Ingredients:40
NDAs:53
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
acetaminophen; hydrocodone bitartrate
TABLET;ORAL206245-001Dec 1, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL204021-004Jun 12, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
NITROFURANTOIN
nitrofurantoin
SUSPENSION;ORAL201693-001Sep 8, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET;ORAL207884-003Nov 13, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
POTASSIUM CHLORIDE
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL204828-001Aug 16, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL204330-001Mar 16, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
acetaminophen; hydrocodone bitartrate
TABLET;ORAL206245-002Dec 1, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin hydrochloride
TABLET;ORAL207285-001Feb 13, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
DEXMETHYLPHENIDATE HYDROCHLORIDE
dexmethylphenidate hydrochloride
TABLET;ORAL204534-003Dec 4, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
PHENELZINE SULFATE
phenelzine sulfate
TABLET;ORAL200181-001Dec 8, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Novartis
AstraZeneca
US Army
US Department of Justice
Baxter
Healthtrust
Julphar
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot